Summary

Report Scope
The report analyzes trends in the global market for diagnostics and treatment of thyroid gland disorders. The report includes global revenue ($ million) for the base year 2024, estimated data for 2025, and for the forecast period of 2026 through 2030. The market is segmented by type of disease, product type, end user and region. The disease types are segmented into hypothyroidism, hyperthyroidism, thyroid cancer, and others. Product types are diagnostics and treatments. The diagnostics market is segmented into diagnostic, blood and imaging tests. The treatment market is segmented into medication, thyroid surgery, thyroid eye disease (TED) treatment and other end users are hospitals, specialty clinics, retail and online pharmacies, research and academic institutions, and patient and home care settings. The regions covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW. North American consists of the U.S., Canada, and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe. Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific.
This report focuses on trends and challenges that affect the market, including emerging technologies. It includes an analysis of the competitive landscape, with the rankings and market shares of the leading companies in the global market. The report has a chapter on environmental, social, and corporate governance (ESG) developments and includes company profiles that covers key financials, product portfolios and recent news.
Report Includes
- 97 data tables and 62 additional tables
- An overview of the current and future global markets for thyroid gland disorder
- An analysis of the global market trends with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by type, disease type, end-user industry, and region
- Facts and figures pertaining to market dynamics, technological advances, regulations, and the impact of macroeconomic factors
- Analysis of market opportunities from a Porter’s Five Forces perspective, and a value chain analysis considering the prevailing micro- and macro environmental factors
- Coverage of advances in thyroid cancer diagnosis such as genomic tests and treatments, as well as the side effects of current treatments such as radioactive iodine
- Evaluation of ESG practices in the industry, consumer attitudes towards sustainability, risks and opportunity assessment, ratings and matrices
- A patent analysis with emphasis on emerging technologies and new developments in the market
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Company profiles of major players within the industry, including Amgen Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Bristol-Myers Squibb Co., and Pfizer Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Conventional and Novel Technologies
Diagnostics in Thyroid Gland Disorders
Treatment of Thyroid Gland Disorders
Porter’s Five Forces Analysis
Potential for New Entrants (Moderate)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (Moderate to High)
Threat of Substitutes (Low to Moderate)
Industry Competitiveness (High)
Macroeconomic Factors
Aging Population
Regulatory Environment
Growing Incidence of Cancer
Government Policy and Collaboration
Chapter 3 Market Dynamics
Market Drivers
Growing Prevalence of Thyroid Cancer
Growing Prevalence of Thyroid Disorders
Rising Awareness and Policy Initiatives for Thyroid Disorders
Managing Thyroid Disorders through Personalized Medicine
Market Restraints
Side Effects of Treatment
Limited Access in Low-Income Regions
Market Opportunities
Incorporation of AI
Advanced Therapeutics
Market Challenges
Healthcare Disparities and Funding Challenges
Requirement for Lifelong Medication
Chapter 4 Regulatory Landscape
U.S. Approval Process
EU Approval Process
Asia-Pacific Approval Process
Drug Approval and Regulations
Levothyroxine-Based Treatments
Anti-Thyroid Medications
Biologic and Biosimilar Regulations
Medical Devices and Diagnostics Regulations
Point-of-Care and Laboratory Tests
Wearable and Digital Health Solutions
Future Trends and Regulatory Changes
Chapter 5 Emerging Technologies and Developments
Overview
Emerging Technologies in Thyroid Disorder Diagnostics
Hybrid Feature Selection and Deep Learning Framework
Autofluorescence Technology for Thyroid and Parathyroid Surgery
Regenerative Medicine and Bioengineering
Biowearable Technology
Mobile Apps
Recent Approvals and Launches of Drug and Device Products
Patent Analysis
Findings
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Key Takeaways
Market Analysis by Disease Type
Hypothyroidism
Hyperthyroidism
Thyroid Cancer
Other Diseases
Market Analysis by Type
Takeaways
Diagnostics
Treatment
Market Analysis by End User
Takeaways
Treatment in Hospitals and Specialty Clinics
Retail and Online Pharmacies
Research and Academic Institutes
Home Care Settings
Geographic Breakdown
Market Analysis by Region
Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Takeaways
Market Shares of Leading Companies
Developments and Strategies
Agreements, Collaborations and Partnerships
Acquisitions
Chapter 8 Sustainability in the Diagnostics and Treatment of Thyroid Gland Disorders Industry: ESG Perspective
Introduction to ESG
Initiatives by Leading Companies
ESG Risk Ratings
BCC Research Viewpoint
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
FRESENIUS SE & CO. KGAA
GSK PLC.
LILLY
MERCK KGAA
NOVARTIS AG
PFIZER INC.
SANOFI
SIEMENS HEALTHINEERS AG
TERUMO CORP.
Emerging Start-ups/ Market Disruptors